Tandem Diabetes Care Shares Rise After FDA Clears Tubeless Insulin System
Tandem Diabetes Care shares rose after the company obtained U.S. FDA clearance for a tubeless automated insulin delivery system.
Tandem Diabetes Care shares rose after the company obtained U.S. FDA clearance for a tubeless automated insulin delivery system.